Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity

<p>Figure S1</p>

Spremljeno u:
Bibliografski detalji
Glavni autor: Shiyi Yu (17079079) (author)
Daljnji autori: Ying Wang (17079082) (author), Xue Gong (17079085) (author), Zhehao Fan (17079088) (author), Zheng Wang (17079091) (author), Zhengyan Liang (17079094) (author), Rui Wu (17079097) (author), Binjie Cao (17079100) (author), Ning Wang (17079103) (author), Caili Bi (17079106) (author), Dan Lv (17079109) (author), Haibo Sun (17079112) (author)
Izdano: 2025
Teme:
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
_version_ 1849927637900722176
author Shiyi Yu (17079079)
author2 Ying Wang (17079082)
Xue Gong (17079085)
Zhehao Fan (17079088)
Zheng Wang (17079091)
Zhengyan Liang (17079094)
Rui Wu (17079097)
Binjie Cao (17079100)
Ning Wang (17079103)
Caili Bi (17079106)
Dan Lv (17079109)
Haibo Sun (17079112)
author2_role author
author
author
author
author
author
author
author
author
author
author
author_facet Shiyi Yu (17079079)
Ying Wang (17079082)
Xue Gong (17079085)
Zhehao Fan (17079088)
Zheng Wang (17079091)
Zhengyan Liang (17079094)
Rui Wu (17079097)
Binjie Cao (17079100)
Ning Wang (17079103)
Caili Bi (17079106)
Dan Lv (17079109)
Haibo Sun (17079112)
author_role author
dc.creator.none.fl_str_mv Shiyi Yu (17079079)
Ying Wang (17079082)
Xue Gong (17079085)
Zhehao Fan (17079088)
Zheng Wang (17079091)
Zhengyan Liang (17079094)
Rui Wu (17079097)
Binjie Cao (17079100)
Ning Wang (17079103)
Caili Bi (17079106)
Dan Lv (17079109)
Haibo Sun (17079112)
dc.date.none.fl_str_mv 2025-11-24T23:22:49Z
dc.identifier.none.fl_str_mv 10.1158/0008-5472.30701123
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Figure_S1_from_LncRNA_AGPG_Confers_Endocrine_Resistance_in_Breast_Cancer_by_Promoting_E2F1_Activity/30701123
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Breast Cancer
Cell Cycle
Signal transduction pathways
Drug Resistance
Regulation of gene expression in drug resistance
Endocrine-Related Cancers
dc.title.none.fl_str_mv Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Figure S1</p>
eu_rights_str_mv openAccess
id Manara_8c349180f1efffacebaa45b6f8cc04bb
identifier_str_mv 10.1158/0008-5472.30701123
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30701123
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 ActivityShiyi Yu (17079079)Ying Wang (17079082)Xue Gong (17079085)Zhehao Fan (17079088)Zheng Wang (17079091)Zhengyan Liang (17079094)Rui Wu (17079097)Binjie Cao (17079100)Ning Wang (17079103)Caili Bi (17079106)Dan Lv (17079109)Haibo Sun (17079112)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentBreast CancerCell CycleSignal transduction pathwaysDrug ResistanceRegulation of gene expression in drug resistanceEndocrine-Related Cancers<p>Figure S1</p>2025-11-24T23:22:49ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/0008-5472.30701123https://figshare.com/articles/figure/Figure_S1_from_LncRNA_AGPG_Confers_Endocrine_Resistance_in_Breast_Cancer_by_Promoting_E2F1_Activity/30701123CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307011232025-11-24T23:22:49Z
spellingShingle Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Shiyi Yu (17079079)
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Breast Cancer
Cell Cycle
Signal transduction pathways
Drug Resistance
Regulation of gene expression in drug resistance
Endocrine-Related Cancers
status_str publishedVersion
title Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
title_full Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
title_fullStr Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
title_full_unstemmed Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
title_short Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
title_sort Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
topic Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Breast Cancer
Cell Cycle
Signal transduction pathways
Drug Resistance
Regulation of gene expression in drug resistance
Endocrine-Related Cancers